Articles tagged with Gene Regulation
Researchers found that the deletion of the Gtf2i gene impairs mitochondrial organelle formation and function, leading to abnormal cell behavior and neurodevelopmental pathologies. This discovery sheds light on the mechanism behind Williams syndrome, a rare genetic disorder characterized by cognitive and social impairments.
Researchers found a shared genetic trait that predicts a higher risk of small lung vessel disease and its severe form, pulmonary arterial hypertension. This discovery could lead to personalized treatments for patients with limited oxygen response.
Researchers at Baylor College of Medicine have developed a technology to effectively regulate gene expression, promising a safer approach to gene therapy. The system uses small molecules to interact with RNA, allowing for precise control over protein production and therapeutic window maintenance.
Researchers at Salk Institute assembled the most complete atlas of the mouse brain by analyzing over 2 million brain cells. The detailed atlas reveals thousands of cell types, their connections, genes, and regulatory programs active in each cell, providing new insights into human disease vulnerabilities.
Researchers from the University of California, Berkeley, and the University of Oxford found that formaldehyde inhibits DNA methylation, turning genes on or off. The study suggests that high levels of formaldehyde may suppress the body's attempts to prevent cancer.
A study published in Nature Communications sheds light on the critical role of P4-ATPases, particularly ATP8B1-CDC50A, in maintaining lipid asymmetry in cell membranes. The research team used cryo-electron microscopy to determine the structure and function of the human flippase complex, revealing its regulation by phosphoinositides.
Researchers at Salk Institute uncover a mechanism for repairing damaged nerves during peripheral neuropathy, with protein Mitf playing a key role. The findings have the potential to inspire novel therapeutics that bolster repair function and heal peripheral neuropathy.
Scientists at St. Jude Children's Research Hospital identified genes directly regulated by the oncogenic HOXA9 protein in high-risk pediatric leukemias. The study found two major targets, FLT3 and CDK6, which can be therapeutically targeted with drugs, showing promising outcomes in preclinical models. Additionally, researchers discover...
Researchers found that cancer cells are more vulnerable to radiotherapy when using the less common 'YC' first-base-cytosine site instead of the usual 'YR' adenine or guanine start sites. This discovery enables further understanding of gene regulation in cancers and potential targets for treatment.
Researchers at Goethe University Frankfurt have identified a specific gene locus, MYNRL15, that is critical to the survival and replication of leukemia cells. Inhibiting this gene has been shown to deactivate genes necessary for AML cell survival, offering a new possibility for fighting leukemia.
Researchers discuss a new approach integrating genomic, epigenomic, transcriptomic, and machine learning methods to identify functional genetic variants and characterize their mode of action in regulating target genes. This method aims to improve understanding of disease etiology and prioritize causative inherited genetic variants.
Researchers at Duke University developed a CRISPR-based platform to identify genes that improve T-cell therapies for cancer treatment. They discovered BATF3, a single master regulator of the genome, which reprograms thousands of genes in T cells and greatly enhances cancer cell killing.
The German Research Foundation has renewed funding for the Research Training Group 'Gene Regulation in Evolution' at Mainz University, focusing on the role of gene regulation in adaptation and evolution. The program will recruit 13 new doctoral students and continue to support interdisciplinary research and personal development.
Researchers have identified a common mutation in the transcription factor IRF4 that drives tumor cell development in Hodgkin's lymphoma. This mutation leads to the activation of disease-relevant genes, and blocking its effects could provide new therapeutic opportunities.
A recent study reveals that CAMSAP1 plays a crucial role in regulating the structure and dynamics of manchette microtubule minus-ends, impacting male fertility during spermiogenesis. The absence of CAMSAP1 leads to abnormal sperm development, including reduced sperm quantity, decreased motility, and male infertility.
Researchers discovered a malaria protein, PfAP2-P, that plays a key regulatory role in immune evasion and parasite development. This protein acts as an activator of proteins required for the parasite to exit infected red blood cells and invade new ones.
A new versatile platform controls peptide hormones in fish, revealing surprising findings about conserved genetic networks and adaptable hormone regulation. This innovative method holds promise for transforming fish farming practices and exploring ways to prolong vertebrate lifespan.
Researchers from Columbia University have validated GLS2's ability to promote ferroptosis in murine models. This study suggests that targeting GLS2 may be a potential therapeutic strategy against liver diseases, particularly hepatocellular carcinoma.
Researchers at Chalmers University of Technology have shown that graphene oxide nanoflakes can reduce the accumulation of misfolded amyloid peptides in yeast cells, which are similar to human neurons affected by Alzheimer's disease. This suggests that graphene oxide may hold great potential for treating neurodegenerative diseases.
Researchers discovered that intrinsically disordered regions (IDRs) in proteins play a critical role in chromatin regulation and gene expression. IDRs form droplets called condensates that separate from surrounding fluid, allowing proteins to congregate and carry out cellular activities.
A genome study of over 600 carrot types finds that recessive genes controlling orange carotenoids are essential for the vegetable's orange color. The study also sheds light on carrot domestication in Western Asia and Europe during the Middle Ages and Renaissance periods, respectively.
Scientists at CU Boulder and Harvard Medical School discovered how RNA regulates PRC2 activity, enabling genes in certain regions of the genome to keep firing while others remain off. This finding sheds light on development and could pave the way for novel therapeutics for hard-to-treat cancers.
Researchers have developed a new method to detect microRNA targets at the level of single cells, allowing for detailed study of gene regulation. This breakthrough enables researchers to follow microRNA targeting of thousands of RNAs during biological processes, revealing surprising complexity in each cell.
A team of researchers at Tokyo Medical and Dental University has identified a gene called Rasip1 as crucial for blood cell development. SOX17, a transcription factor, is found to activate Rasip1, leading to the formation of hematopoietic stem cells and associated hematopoietic activity.
Endurance training triggers profound muscle remodeling, with trained muscles responding differently to physical stress by activating protective genes and epigenetic modifications. This adaptation enables trained muscles to be more efficient and resilient, ultimately leading to increased muscle endurance.
Researchers have provided new insights into the role of lipid droplet-localized CETN-SPDL1-L in regulating cone cell lipid droplet localization, crucial for light sensitivity. The study discovered centrin proteins and SPDL1-L collaborate to maintain correct lipid droplet placement.
Researchers have found that the protein Musashi-2 plays a crucial role in regulating type 2a muscle fiber mass and metabolism. The study reveals that Msi2 knockout mice exhibit reduced muscle mass, decreased myoglobin and mitochondria levels, and impaired sugar metabolism.
A team of KAUST researchers has found a critical protein that regulates cell division and proliferation in breast cancer and leukemia. Their work clears the way for the development of targeted drugs by refuting recent challenges to their approach.
Scientists at The Wistar Institute have discovered a potential target for gastric cancers associated with the Epstein-Barr Virus. Decitabine treatment disrupts the cancer's epigenetic profile, reactivating the lytic cycle of the latent EBV and leading to cell death.
Researchers developed a method to design weaker transcription factors that work together to activate genes without activating naturally occurring genes. This approach, called cooperative assembly, strengthens the factors as a group but weakens them individually, ensuring targeted gene activation and long-term circuit stability.
A study published in Science has identified 135 previously unknown genes associated with pigmentation, shedding light on the regulation of melanin production in humans. The research could help protect lighter-skinned individuals from skin cancer and develop new treatments for vitiligo and other pigmentation diseases.
Researchers have discovered a novel pathway that minimizes liver injury during transplantation by activating the protective CEACAM1-S version. This protective characteristic is regulated by HIF-1α and can be enhanced using molecular tools and alternative gene splicing, reducing organ injury and improving post-transplant outcomes.
Researchers discovered lactate's role in helping neural stem cells develop into specialized neurons. Lactate sends signals to cells, modifying and strengthening neuronal functions. The study provides insight into lactate signaling in the nervous system, with potential applications for preventing or controlling cognitive diseases.
A joint study reveals significant alterations in gene regulation within the placenta due to COVID-19 infection, potentially leading to abnormal blood vessel formation and fetal growth restriction. The research also identifies dysregulation of angiogenesis genes and downregulation of pregnancy-specific glycoprotein genes.
A recent study by the Eustermann group at EMBL Heidelberg reveals that DNA packaging into hexasomes impacts the function of enzymes involved in gene regulation. The researchers used cryo-electron microscopy to visualize the molecular processes of how this packaging regulates genome expression and maintenance.
Researchers investigated hepatic hydrogen sulfide production in a mouse model of Hutchinson-Gilford Progeria Syndrome (HGPS) and found reduced H2S levels in RC-fed mice, with partial rescue on high-fat diet. This study suggests that accelerated aging in HGPS may be partially explained by reduced hepatic H2S levels.
Researchers discovered that a diet rich in the bacteria Lactobacillus reuteri can maintain associative learning ability in older nematodes. This finding suggests potential ways to use diet to reduce age-related cognitive decline in other animals, including humans.
Researchers discovered a TIR1/AFB-independent auxin signaling mechanism in Klebsormidium nitens, a primitive alga. They identified KnRAV as a key transcription factor that activates auxin-inducible genes and binds to promoter sequences.
The study found that drug-resistant Leishmania parasites have distinct protein production profiles compared to sensitive parasites, suggesting a global reprogramming of protein synthesis. This pre-emptive adaptation enables the parasite to quickly respond to the presence of the drug and survive when it is absent.
Researchers developed Genome Architecture Mapping (GAM) to study DNA interactions, revealing novel three-dimensional configurations that were invisible to Hi-C. This technique provides a more comprehensive understanding of genome organization and its impact on health and disease.
Researchers have identified DYRK1A as a key regulator of the SARS-CoV-2 viral receptor, which is critical for entry into human tissues. Reducing DYRK1A activity decreases infection, providing new insights into COVID-19 causation and potential antiviral treatments.
Researchers at NYU Abu Dhabi identified microRNAs associated with a weakened immune response and ICU admission. The study provides new insights into how patient genetic makeup affects disease severity and offers potential biomarkers for disease monitoring.
Scientists at University of Virginia Health System discovered a gene that acts as a master controller for immune tolerance, shedding light on how our immune systems are calibrated to prevent MS. The new understanding could lead to better, more targeted treatments.
LSU Health New Orleans researchers found that a combination therapy using Neuroprotectin D1 and Resolvin D1 boosted brain cell survival, growth, and stability. The therapy showed promising results in reducing lesion volume and improving neurological function in acute ischemic stroke models.
Researchers at The Hospital for Sick Children identified high densities of variants linked to blood pressure genes in the non-coding genome. The study uses massively parallel reporter assay technology to examine genetic variants and provides a functional map of regulators of blood pressure genes.
Scientists using popular computational tools to interpret AI predictions are picking up too much 'noise' when analyzing DNA. Researchers have found a way to fix this by applying a new line of code, leading to more reliable explanations and potentially unlocking the next breakthrough in health and medicine.
Researchers analyzed BORIS mutations and protein expression in breast cancer tissue samples, finding frequent mutations associated with breast carcinoma progression. The study suggests the BORIS gene as a potential biomarker for breast cancer.
Researchers identified mRNAs and long non-coding RNAs targeted by stress granule proteins, which accumulate AD-associated gene transcripts in these structures. SGs may play a key role in regulating AD development through the impairment of protein neurohomeostasis.
Researchers discovered that ZC3H11A is essential for regulating metabolic genes in embryos and their absence leads to complete lethality. The study's findings suggest that ZC3 may be a promising therapeutic target for the development of anti-viral agents against medically significant human viruses.
A new study by North Carolina State University researchers finds that sucralose-6-acetate, a chemical formed when we digest sucralose, is genotoxic and breaks up DNA. The chemical is also present in trace amounts in the sweetener itself, posing potential health risks.
Researchers found that MALAT1 inhibition decreased BRAF RNA and protein levels, while increasing correlation with MAPK-associated genes. MALAT1-ASO treatment also reduced melanoma cell growth and tumor size in xenograft models.
Researchers found that apoE4 poorly binds factor H, a regulatory factor of immunity, leading to amyloid-β oligomerization and neuroinflammation. This could be a potential solution to preventing Alzheimer's disease, with further research needed to find a bridging molecule.
Researchers at UCL have uncovered the molecular basis of a woman's rare genetic mutation that allows her to live pain-free and heal rapidly. The study found that the mutation in the FAAH-OUT gene turns down FAAH gene expression, affecting other molecular pathways linked to wound healing and mood.
Researchers create high-resolution maps of the 3D genome, revealing interactions between enhancers and promoters that weren't previously seen. The findings suggest many genes interact with dozens of regulatory elements, opening possibilities for studying gene regulation and potentially understanding diseases.
Researchers have developed a new method called EvoAug that uses artificial DNA sequences inspired by evolution to train deep neural networks for genome analysis. This approach enables the model to recognize regulatory motifs more accurately, leading to better performance and potential breakthroughs in understanding human health.
Scientists discovered that inhibiting microRNA-141-3p can reduce chronic inflammation, muscle loss, and bone degradation in aged mice. By blocking this tiny RNA, researchers found improvements in the spleen's immune response, lower levels of pro-inflammatory proteins, and a more youthful profile in bones and muscles.
A large-scale genomic study of 240 mammal species reveals previously uncharacterized regulatory elements in the human genome, linked to disease risks and distinctive traits. The research provides insights into the evolutionary development of mammalian genomes and their potential applications in medical research.
Researchers have engineered a synthetic gene oscillator device that slows down the aging process in yeast cells by cycling deterioration between two detrimental states. This approach resulted in an 82% increase in lifespan compared to control cells, setting a new record for life extension through genetic and chemical interventions.
Researchers from Penn State and Ohio State University used structural biology, biophysics, and cell biology to understand how pioneer factors interact with nucleosomes. They found that a specific region of the protein helps it access DNA, making it accessible for proteins involved in gene expression.
A Mayo Clinic study found that people with severe obesity and a genetic pathway variant are at increased risk of developing hypertension. The research identified 168 carriers of the MC4R variant, who had a higher risk of hypertension compared to noncarriers.